Back
Markel Group Vs. Akero Therapeutics Industry Stock Comparison
Buy
53
MKL
Markel Group
Last Price:
$1,835.84
Seasonality Move:
8%
Buy
57
AKRO
Akero Therapeutics
Last Price:
$56.72
Seasonality Move:
-13.54%
Buy
53
Markel Group (MKL)
is a Buy
Is Markel Group a Buy, Sell or Hold?
-
The current Markel Group [MKL] share price is $1,803.03. The Score for MKL is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
MKL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
57
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $54.00. The Score for AKRO is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MKL Stock Price Chart
What is Markel Group's stock price today?
-
The Markel Group share price today is $1,803.03Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MKL is experiencing selling pressure, which indicates risk of future bearish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $54.00Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight buying pressure.
MKL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 27.32 | Buy |
Relative Strength Index (14 RSI): | 61.63 | Buy |
Chaikin Money Flow: | -38011 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1702.58 - 1796.04) | Buy |
Bollinger Bands (100): | (1566.71 - 1749.99) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.24 | Buy |
Relative Strength Index (14 RSI): | 85.85 | Buy |
Chaikin Money Flow: | 423269 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.76 - 38.18) | Buy |
Bollinger Bands (100): | (24.88 - 34.36) | Buy |
MKL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1807.04 | Sell |
20-day SMA: | 1751.05 | Buy |
50-day SMA: | 1742.54 | Buy |
200-day SMA: | 1610.9 | Buy |
8-day EMA: | 1800.48 | Buy |
20-day EMA: | 1769.53 | Buy |
50-day EMA: | 1729.45 | Buy |
200-day EMA: | 1621.56 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 35.66 | Buy |
20-day SMA: | 29.67 | Buy |
50-day SMA: | 29.97 | Buy |
200-day SMA: | 26.38 | Buy |
8-day EMA: | 39.78 | Buy |
20-day EMA: | 32.93 | Buy |
50-day EMA: | 30.49 | Buy |
200-day EMA: | 28.24 | Buy |
Markel Group Earnings Growth & MKL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.94 per share, a decrease next quarter of $0.00 per share, an increase this year of $10.62 per share, and an increase next year of $13.58 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and an increase next year of $0.08 per share.
Markel Group Technical Analysis
Jan 15 | Jan 16 | Jan 17 | Jan 21 | Jan 22 | Jan 23 | Jan 24 | Jan 27 | Jan 28 | Jan 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
15 | 16 | 17 | 21 | 22 | 23 | 24 | 27 | 28 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Jan 15 | Jan 16 | Jan 17 | Jan 21 | Jan 22 | Jan 23 | Jan 24 | Jan 27 | Jan 28 | Jan 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
15 | 16 | 17 | 21 | 22 | 23 | 24 | 27 | 28 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |